Fourteen-year follow-up from CABADAS: Vitamin K antagonists or dipyridamole not superior to aspirin

Annals of Thoracic Surgery

Volumn 90, Issue 5, 2010, Pages 1515-1521

  Veeger, Nic J G M ^a   Zijlstra, Felix ^a   Hillege, Hans L ^a   Van Der Meer, Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; DIPYRIDAMOLE; PHENPROCOUMON; ANTICOAGULANT AGENT; VITAMIN K GROUP;

ADULT; AGED; ANGINA PECTORIS; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REOPERATION; TREATMENT OUTCOME; ANTAGONISTS AND INHIBITORS; FOLLOW UP; GRAFT OCCLUSION, VASCULAR; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ACENOCOUMAROL; AGED; ANTICOAGULANTS; ASPIRIN; CORONARY ARTERY BYPASS; DIPYRIDAMOLE; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PHENPROCOUMON; VITAMIN K;

EID: 78049296543     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.06.007     Document Type: Article

References (16)

1. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapyII: Maintenance of vascular graft or arterial patency by antiplatelet therapy BMJ 308 1994 159 168
2. R.C. Becker, T.W. Meade, and P.B. Berger The primary and secondary prevention of coronary artery disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 Suppl 2008 776 814
3. K.A. Eagle, R.A. Guyton, and R. Davidoff ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1999 guidelines for coronary artery bypass graft surgery) J Am Coll Cardiol 44 2004 e213 e310
4. J.H. Chesebro, V. Fuster, and L.R. Elveback Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations N Engl J Med 310 1984 209 214
5. R.L. Lorenz, C.V. Schacky, and M. Weber Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily) Effects on platelet aggregation and thromboxane formation Lancet 1 1984 1261 1264
6. D.T. Mangano Aspirin and mortality from coronary bypass surgery N Engl J Med 347 2002 1309 1317
7. G.V. Sharma, S.F. Khuri, M. Josa, E.D. Folland, and A.F. Parisi The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency Circulation 68 1983 II218 II221
8. J. van der Meer, H.L. Hillege, and G.J. Kootstra Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants The CABADAS Research Group of the Interuniversity Cardiology Institute of the Netherlands Lancet 342 1993 257 264
9. A.A. Cameron, G.E. Green, D.A. Brogno, and J. Thornton Internal thoracic artery grafts: 20-year clinical follow-up J Am Coll Cardiol 25 1995 188 192
10. J. Daemen, E. Boersma, and M. Flather Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials Circulation 118 2008 1146 1154
11. The BARI Investigators The final 10-year follow-up results from the BARI randomized trial J Am Coll Cardiol 49 2007 1600 1606
12. B.L. van Brussel, A.A. Voors, J.M. Ernst, P.J. Knaepen, and H.W. Plokker Venous coronary artery bypass surgery: a more than 20-year follow-up study Eur Heart J 24 2003 927 936
13. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 1996 217 225
14. P.W. Serruys, F. Unger, and J.E. Sousa Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease N Engl J Med 344 2001 1117 1124 (Pubitemid 32285232)
15. P.W. Serruys, A.T. Ong, and L.A. van Herwerden Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial J Am Coll Cardiol 46 2005 575 581
16. J. van der Meer, A. Brutel de la Riviere, and W.H. van Gilst Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year CABADAS Research Group of the Interuniversity Cardiology Institute of the Netherlands Prevention of coronary artery bypass graft occlusion by aspirin, dipyridamole and acenocoumarol/phenprocoumon study J Am Coll Cardiol 24 1994 1181 1188